Algert Global LLC Alkermes Plc. Transaction History

Algert Global LLC

$5.98 Billion
Q3 2025

A detailed history of Algert Global LLC transactions in Alkermes Plc. stock. As of the latest transaction made, Algert Global LLC holds 135,970 shares of ALKS stock, worth $3.95 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

135,970

Previous 115,270 17.96%

Holding current value

$3.95 Million

Previous $3.3 Million 23.68%

% of portfolio

0.07%

Previous 0.07%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$26.13 - $30.46 $540,891 - $630,522	20,700 Added 17.96%	135,970 $4.08 Million
Q2 2025 Aug 13, 2025	SELL	$26.59 - $32.65 $1.64 Million - $2.01 Million	-61,589 Reduced 34.82%	115,270 $3.3 Million
Q1 2025 May 13, 2025	BUY	$28.08 - $36.0 $4.97 Million - $6.37 Million	176,859 New	176,859 $5.84 Million
Q2 2024 Aug 14, 2024	BUY	$23.21 - $27.24 $375,793 - $441,042	16,191 New	16,191 $390,000
Q4 2023 Feb 14, 2024	SELL	$23.37 - $28.68 $2.74 Million - $3.36 Million	-117,282 Reduced 43.67%	151,261 $4.2 Million

Q3 2023 Nov 13, 2023	BUY	$27.17 - $31.97 $1.7 Million - $2 Million	62,674 Added 30.44%	268,543 $7.52 Million
Q2 2023 Aug 14, 2023	BUY	$28.34 - $33.63 $288,217 - $342,017	10,170 Added 5.2%	205,869 $6.44 Million
Q1 2023 May 12, 2023	BUY	$25.31 - $29.02 $475,802 - $545,546	18,799 Added 10.63%	195,699 $5.52 Million
Q4 2022 Feb 13, 2023	BUY	$21.94 - $26.24 $166,436 - $199,056	7,586 Added 4.48%	176,900 $4.62 Million
Q3 2022 Nov 15, 2022	BUY	$22.0 - $31.87 $1.54 Million - $2.23 Million	70,008 Added 70.5%	169,314 $3.78 Million
Q2 2022 Aug 15, 2022	BUY	$26.4 - $30.54 $1.15 Million - $1.33 Million	43,702 Added 78.6%	99,306 $2.96 Million
Q1 2022 May 16, 2022	BUY	$23.07 - $27.99 $1.28 Million - $1.56 Million	55,604 New	55,604 $1.46 Million
Q4 2021 Feb 14, 2022	SELL	$21.47 - $32.08 $379,503 - $567,046	-17,676 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$23.37 - $32.13 $413,088 - $567,929	17,676 New	17,676 $545,000

Others Institutions Holding ALKS

# of Institutions

401

Shares Held

176M

Call Options Held

901K

Put Options Held

400K

View Full List

About Alkermes plc.

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.77B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

More about ALKS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

News

Stay updated on Algert Global LLC with notifications on news.

Account

Algert Global LLC Alkermes Plc. Transaction History